Back to search

United Kingdom· GB-APID-29910511000001105

Teragezza 2000microgram/35microgram tablets

A medicinal product containing co-cyprindiol, registered in United Kingdom by Morningside Healthcare Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedTeragezza 2000microgram/35microgram t…ATC—REGISTER NO.GB-APID-2991051100000…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Co-cyprindiol
Manufacturer
Morningside Healthcare Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5055132715396

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/deb25b67-f7dd-4d3e-b1de-02983d52a4e3
GET /v1/drugs/deb25b67-f7dd-4d3e-b1de-02983d52a4e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "29910511000001105",
  "desc": "Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd)",
  "form": "Oral tablet",
  "vpid": "41872911000001109",
  "source": "dmd",
  "vtm_id": "18036911000001101",
  "strength": "35 microgram",
  "substance": "Co-cyprindiol",
  "ingredient": "Ethinylestradiol",
  "supplier_code": "10246711000001109"
}

See everything about co-cyprindiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.